Free Trial

Kinaxis Inc. (TSE:KXS) Given Average Recommendation of "Moderate Buy" by Analysts

Kinaxis logo with Computer and Technology background

Key Points

  • Kinaxis Inc. has received a consensus rating of "Moderate Buy" from six analysts, with an average one-year price target of C$221.43.
  • Recent target price increases by analysts include Scotiabank's recommendation of C$240.00 and Stifel Nicolaus’s raise to C$245.00.
  • Insider selling activity includes Mark Justin Morgan selling 2,281 shares, which reduced his stake in the company by 17.17%.
  • Five stocks to consider instead of Kinaxis.

Shares of Kinaxis Inc. (TSE:KXS - Get Free Report) have earned a consensus rating of "Moderate Buy" from the six analysts that are presently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is C$221.43.

A number of equities analysts have issued reports on KXS shares. Scotiabank raised their target price on shares of Kinaxis from C$225.00 to C$240.00 and gave the stock an "outperform" rating in a report on Friday, August 8th. Stifel Nicolaus raised their price target on shares of Kinaxis from C$225.00 to C$245.00 and gave the company a "buy" rating in a research note on Thursday, July 31st. Royal Bank Of Canada raised their price target on shares of Kinaxis from C$225.00 to C$235.00 in a research note on Friday, August 8th. Finally, TD Securities raised their price target on shares of Kinaxis from C$190.00 to C$225.00 and gave the company a "buy" rating in a research note on Friday, October 3rd.

View Our Latest Analysis on KXS

Insider Buying and Selling at Kinaxis

In other Kinaxis news, insider Mark Justin Morgan sold 2,281 shares of the firm's stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of C$198.63, for a total value of C$453,081.87. Following the sale, the insider owned 11,000 shares in the company, valued at approximately C$2,184,963. This trade represents a 17.17% decrease in their ownership of the stock. Also, Director Angel Luis Mendez sold 6,100 shares of the firm's stock in a transaction that occurred on Thursday, August 28th. The shares were sold at an average price of C$190.00, for a total transaction of C$1,159,000.00. Following the completion of the sale, the director owned 1,400 shares in the company, valued at C$266,000. The trade was a 81.33% decrease in their position. Over the last 90 days, insiders have sold 8,656 shares of company stock worth $1,665,206. 1.20% of the stock is owned by company insiders.

Kinaxis Stock Performance

Shares of TSE KXS opened at C$182.12 on Friday. The company has a quick ratio of 2.29, a current ratio of 1.89 and a debt-to-equity ratio of 12.12. The firm's 50-day moving average price is C$188.94 and its two-hundred day moving average price is C$189.60. Kinaxis has a 52-week low of C$149.96 and a 52-week high of C$212.45. The stock has a market capitalization of C$5.15 billion, a P/E ratio of 211.77, a P/E/G ratio of 3.60 and a beta of 0.77.

About Kinaxis

(Get Free Report)

Kinaxis Inc is a Canada-based provider of software solutions for sales and operations planning (S&OP) and supply chain management. The firm's flagship RapidResponse product is offered on the cloud. Its capabilities include consequence evaluation and alerting, responsibility-based collaboration, high-speed analytics, and scenario simulation.

See Also

Analyst Recommendations for Kinaxis (TSE:KXS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Kinaxis Right Now?

Before you consider Kinaxis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kinaxis wasn't on the list.

While Kinaxis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.